Mobile Menu
Australia
AU 459085 | Enterprise Profile

Respiri Limited

IW
IBISWorld Research Department
Analyst Australia

Respiri is a Public Company that generates the majority of its income from the Medical & Surgical Equipment Manufacturing industry. In 2025 the company generated total revenue of $3,094,000 including sales and other revenue. The exact number of employees for this organisation is not available. The Chief Executive of Respiri is Mr Marjan Mikel whose official title is Managing Director. The Chairman of Respiri is Mr Nicholas Smedley whose official title is Executive Chairman. Respiri Limited is an ASX-listed company in the medical devices industry. Operating throughout Australia, the Company's product, Wheezo is used by Australians with asthma. The mobile application is able to record and analyze breath sounds to detect wheezing - a typical symptom of asthma. The company also provides respiritory health management services for the US healthcare market.

Continue reading

Access this data your way

The Respiri Limited Industry analysis is available in multiple formats to fit seamlessly into your workflow.

IBISWorld Industry Report platform

IBISWorld Platform

Answer any industry question in minutes with our entire database at your fingertips.

Screen of code example for the IBISWorld api

API Data Delivery

Feed trusted, human-driven industry intelligence straight into your platform.

IBISWorld Data integration with a Client user interface

Integrations

Streamline your workflow with IBISWorld’s intelligence built into your toolkit.

What's included in this industry analysis

IBISWorld's research coverage on the Respiri Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.

Download a sample

Access a free sample of a full enterprise profile.

Download sample

Company Details

What’s this enterprise profile about?

Respiri Limited, trading as Respiri, operates under the ABN 98 009 234 173 and was incorporated on 07 May 1987. Respiri Limited trades on the Australian Securities Exchange under the ticker code ASX:RSH. Respiri Limited primarily operates in the Medical & Surgical Equipment Manufacturing industry in Australia.

Key Personnel

What’s included in the Key Personnel chapter?

The Key Personnel chapter outlines the principal leadership positions within Respiri Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.

Financials

What’s included in the Financials chapter?

The Financials chapter presents Respiri Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.

Growth & Ratios

What’s included in the Growth & Rations chapter?

The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.

Operating Segments

What’s included in the Operating Segments chapter?

The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Respiri Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.

Competitor Benchmarking

What’s included in the Competitor Benchmarking chapter?

The Competitor Benchmarking chapter includes a comparative assessment of Respiri Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.

Shareholders

What’s included in the Shareholders chapter?

The Shareholders chapter provides a breakdown of the ownership structure of Respiri Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.

Subsidiaries

What’s included in the Subsidiaries chapter?

The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Respiri Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.

History

What’s included in the History chapter?

The History chapter presents a overview of Respiri Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.

Trusted by industry professionals

More than 6,000 businesses use IBISWorld to shape local and global economies

We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.

BDO logo

IBISWorld delivers the crisp business knowledge we need to drive our business.  Whether it be serving up our major clients, winning new business or educating  on industry issues, IBISWorld brings real value.

PWC logo

IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.

Australian Trade and Investment Commission logo

When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.

Citi Bank logo

10,000,000+ Data points

100% Industry analyst verified

50,000 + Industry titles

Frequently Asked Questions

What is Respiri Limited?

Respiri Limited is an ASX-listed company in the medical devices industry. Operating throughout Australia, the Company's product, Wheezo is used by Australians with asthma. The mobile application is able to record and analyze breath sounds to detect wheezing - a typical symptom of asthma. The company also provides respiritory health management services for the US healthcare market.

What industry does Respiri Limited operate in?

Respiri Limited, trading as Respiri, is a Public Company that generates the majority of its income from the Medical & Surgical Equipment Manufacturing industry in Australia.

Where is Respiri Limited located?

Murray Cod Australia Limited company is based at 446 Collins Street, Melbourne, Victoria, Australia.

Who is the CEO of Respiri Limited?

The OPERATIONS DECISION MAKER of Respiri Limited is Jenni Lightowlers and the OPERATIONS DECISION MAKER is Mario Gattino.

What was Respiri Limited’s revenue in 2025?

In 2025, Respiri Limited generated total revenue of approximately $3.1 million.

Cut through the noise with intelligence you can trust

/img/content/home/cta-image-1.webp
/img/content/home/cta-image-2.webp
/img/content/home/cta-image-3.webp
/img/content/home/cta-image-4.webp
/img/content/home/cta-image-5.webp